This article is more than 5 years old. Information may no longer be current.

Shire to consider Takeda takeover deal

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Shire’s board may recommend its shareholders accept a bid from the Japanese-based pharmaceutical company Takeda, Shire announced in a press release.

The proposal includes 21.75 pounds in cash and 27.26 pounds in new Takeda shares per Shire share, for a total of approximately 46 billion pounds, the release said.

Shire’s board “would be willing to recommend the revised proposal,” contingent on a resolution of other terms of the offer including an agreement of certain terms, completion of a confirmatory due diligence review, the unanimous and unconditional recommendation of Shire’s board, and final approval by Takeda’s board, the release said.